13Nov
A federal health panel unanimously voted Monday that a drug for Parkinson’s disease from Teva Pharmaceuticals has not been shown to slow progress of the debilitating neurological disease.
Tags: FDA, Parkinson's drug, Teva Pharmaceuticals
